变量 | 总样本量 N = 244 | AKI组 N = 163(66.8%) | 非AKI组 N = 81 (33.2%) | P值 |
患者基线资料 |
|
|
|
|
年龄(年) | 54.1 (9.6) | 54.6 (9.5) | 53.2 (9.7) | 0.23 |
性别,女[例(%)] | 39 (16.0) | 33 (20.2) | 6 (7.4) | 0.01 |
BMI [M(Q), kg/m2] | 24.4 (21.6, 26.6) | 24.7 (22.5, 27.1) | 23.0 (20.8, 25.6) | <0.01 |
个人史 |
|
|
|
|
吸烟史[例(%)] | 88 (36.1) | 59 (36.2) | 29 (35.8) | 0.95 |
饮酒史[例(%)] | 94 (38.5) | 59 (36.2) | 35 (43.2) | 0.29 |
合并症 |
|
|
|
|
高血压[例(%)] | 69 (28.3) | 44 (27.0) | 25 (30.9) | 0.53 |
糖尿病[例(%)] | 86 (35.2) | 58 (35.6) | 28 (34.6) | 0.88 |
高脂血症[例(%)] | 114 (46.7) | 69 (42.3) | 45 (55.6) | 0.05 |
慢性肾脏病[例(%)] | 30 (12.3) | 20 (12.3) | 10 (12.3) | 0.99 |
乙型病毒性肝炎[例(%)] | 125 (51.2) | 78 (47.9) | 47 (58.0) | 0.13 |
丙型病毒性肝炎[例(%)] | 10 (4.1) | 6 (3.7) | 4 (4.9) | 0.64 |
肝性脑病[例(%)] | 17 (7.0) | 11 (6.7) | 6 (7.4) | 0.85 |
腹水[例(%)] | 55 (22.5) | 37 (22.7) | 18 (22.2) | 0.93 |
原发病 |
|
|
| 0.36 |
肝恶性肿瘤合并病毒性肝炎[例(%)] | 103 (42.2) | 65 (39.9) | 38 (46.9) |
|
肝恶性肿瘤[例(%)] | 48 (19.7) | 36 (22.1) | 12 (14.8) |
|
病毒性肝炎[例(%)] | 51 (20.9) | 32 (19.6) | 19 (23.5) |
|
酒精性肝病[例(%)] | 18 (7.3) | 11 (6.7) | 7 (8.6) |
|
其他[例(%)] | 24 (9.8) | 19 (11.7) | 5 (6.2) |
|
肾小球滤过率[M(Q), ml/min·1.73 m2] | 141.5 (105.0, 181.0) | 145.0 (108.4, 186.3) | 129.1 (103.5, 163.3) | 0.14 |
CTP评分 | 8 (7, 9) | 8 (7, 9) | 8 (7, 9) | 0.27 |
MELD评分 | 9 (5, 15) | 10 (6, 16) | 7 (2, 15) | <0.01 |
检验结果 |
|
|
|
|
肌酐[M(Q), mg/dL] | 67 (54, 82) | 65 (50, 78) | 71 (64, 87) | <0.01 |
钠[M(Q), mEq/L] | 140 (138, 142) | 140 (138, 142) | 140 (137, 142) | 0.86 |
白蛋白[M(Q), g/dL] | 35.1 (30.7, 39.9) | 35.0 (30.6, 39.7) | 35.2 (30.9, 40.4) | 0.58 |
总胆红素[M(Q), umol/L] | 46.9 (24.7, 117.2) | 49.1 (26.6, 129.3) | 43.4 (20.9, 108.0) | 0.57 |
血糖[M(Q), mg/dL] | 5.1 (4.5, 6.4) | 5.0 (4.4, 6.4) | 5.2 (4.6, 6.2) | 0.28 |
乳酸[M(Q), mmol/L] | 1.3 (1.0, 1.6) | 1.2 (1.0, 1.6) | 1.3 (1.1, 1.8) | 0.09 |